August 11, 2003 Mr. Alan Littman 83 Shepherd Lane Roslyn Heights, New York 11577 Re: Offer of Employment Dear Alan: clickNsettle.com, Inc., a Delaware corporation, (the "Company"), and its wholly-owned subsidiaries, extend to you an offer of...Employment Agreement • September 25th, 2003 • Clicknsettle Com Inc • Services-business services, nec • New York
COMMON STOCK PURCHASE WARRANT BIOCARDIA, INC.Common Stock Purchase Warrant • August 7th, 2019 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 6, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioCardia, Inc., a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 29th, 2024 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August [__], 2024, between BioCardia, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECOND AMENDMENT TO LEASELease • September 27th, 1999 • Nam Corp • Services-legal services
UNDERWRITING AGREEMENT betweenUnderwriting Agreement • June 19th, 2020 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
As Representative of the several Underwriters named on Schedule 1 attached hereto 590 Madison Avenue, 36th Floor New York, New York 10022
EXHIBIT 4.1 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (the "Agreement"), dated as of this 10th day of May, 2000, by and between NAM Corporation, a Delaware corporation (the "Company"), with offices located at 1010 Northern Boulevard,...Stock Purchase Agreement • May 17th, 2000 • Nam Corp • Services-legal services • New York
EXHIBIT C REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of February 15, 2000, between the investor or investors signatory hereto (each an "Investor" and together the "Investors"), and NAM Corporation, a Delaware...Registration Rights Agreement • March 28th, 2000 • Nam Corp • Services-legal services • New York
BioCardia, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • April 12th, 2022 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
BioCardia, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
PRE-FUNDED COMMON STOCK PURCHASE WARRANT biocardia, INC.Pre-Funded Common Stock Purchase Warrant • June 15th, 2020 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioCardia, Inc., Inc., a Delaware corporation (the “Company”), up to ______ shares of common stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 10.2 EMPLOYMENT AGREEMENT This AGREEMENT (the "Agreement"), dated as of March 15, 2002, is made by and between ROY ISRAEL (the "Executive") and CLICKNSETTLE.COM, INC., a Delaware corporation (the "Company"). WHEREAS, the Executive is currently...Employment Agreement • September 26th, 2002 • Clicknsettle Com Inc • Services-business services, nec
EXHIBIT C REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of February 16, 2000, between Moldbury Holdings Limited ("Investor"), and NAM Corporation, a corporation incorporated under the laws of the State of Delaware (the...Registration Rights Agreement • March 28th, 2000 • Nam Corp • Services-legal services • New York
AT THE MARKET OFFERING AGREEMENTAt the Market Offering Agreement • December 6th, 2023 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
BioCardia, Inc., a corporation organized under the laws of Delaware (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 16th, 2023 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 16, 2023, between BioCardia, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PURCHASE AGREEMENTPurchase Agreement • March 29th, 2021 • BioCardia, Inc. • Biological products, (no disgnostic substances) • Illinois
PURCHASE AGREEMENT (the “Agreement”), dated as of March 29, 2021, by and between BIOCARDIA, INC., a Delaware corporation, (the “Company”), LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).
BIOCARDIA, INC. (f/k/a TIGER X MEDICAL, INC.) INDEMNIFICATION AGREEMENTIndemnification Agreement • October 27th, 2016 • BioCardia, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of ____________ (the “Effective Date”), and is between BioCardia, Inc., a Delaware corporation (the “Company”), and _______________________ (“Indemnitee”).
BioCardia, Inc.Placement Agent Agreement • December 16th, 2020 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
AGREEMENTEmployment Agreement • September 28th, 1998 • Nam Corp • Services-legal services
RECITALS:Asset Purchase Agreement • October 20th, 2004 • Clicknsettle Com Inc • Services-business services, nec • New York
August 17, 1999 Mr. Robert Mack 2633 Raymond Avenue Augusta, Georgia 30904 Re: Offer of Employment Dear Robert: NAM Corporation, a Delaware corporation, (the "Company"), and its wholly-owned subsidiaries, extend to you an offer of employment on the...Employment Agreement • November 15th, 1999 • Nam Corp • Services-legal services • New York
BIOCARDIA, INC.Stock Option Agreement • October 27th, 2016 • BioCardia, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
Unless otherwise defined herein, the terms defined in the 2016 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement (the “Option Agreement”).
RECITALSAdvertising Agreement • September 28th, 2004 • Clicknsettle Com Inc • Services-business services, nec • New York
PRIVATE EQUITY LINE OF CREDIT AGREEMENTPrivate Equity Line of Credit Agreement • March 28th, 2000 • Nam Corp • Services-legal services • New York
AGREEMENTEmployment Agreement • October 14th, 1997 • Nam Corp • Services-legal services
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 27th, 2018 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 24, 2018, between BioCardia, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 29th, 2021 • BioCardia, Inc. • Biological products, (no disgnostic substances) • Illinois
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 29, 2021, by and between BIOCARDIA, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
ContractPlacement Agency Agreement • September 3rd, 2024 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
Subject to the terms and conditions of this letter agreement (the “Agreement”) between A.G.P./Alliance Global Partners, as the sole placement agent (“A.G.P.”) (A.G.P. is also referred to herein as the “Placement Agent”), and BioCardia, Inc., a Delaware corporation (the “Company”), the parties hereby agree that the Placement Agent shall serve as the placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of registered securities of the Company, consisting of: (i) shares of common stock, par value $0.001 per share (“Common Stock”), (ii) pre-funded warrants to purchase Common Stock (the “Pre-Funded Warrants”), and (iii) warrants to purchase Common Stock (the “Common Warrants” and collectively with the Pre-Funded Warrants, the “Warrants”). The Common Stock and Warrants actually placed by the Placement Agent are referred to herein as the “Placement Agent Securities.” The Placement Agent Securities and shares of Commo
BIOCARDIA, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • July 23rd, 2019 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
The undersigned, BioCardia, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of ______________ units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional ____________ Option Shares (as defined herein and collectively with the shares of Common Stock underlying the Firm Units, the “Shares”), and/or up to an additional ___________ Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”) and one Warrant. Each Warrant entitles the holder to purcha
AGREEMENTEmployment Agreement • September 28th, 1998 • Nam Corp • Services-legal services
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 29th, 2009 • Cardo Medical, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
BIOCARDIA, INC. RESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • February 8th, 2017 • BioCardia, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
Unless otherwise defined herein, the terms defined in the BioCardia, Inc. 2016 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Unit Agreement (the “Award Agreement”), which includes the Notice of Restricted Stock Unit Grant (the “Notice of Grant”) and the Terms and Conditions of Restricted Stock Unit Grant, attached hereto as Exhibit A.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 16th, 2020 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 15, 2020, between BioCardia, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 3rd, 2024 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 29, 2024, between BioCardia, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STOCK OPTION AGREEMENTStock Option Agreement • February 8th, 2017 • BioCardia, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Option Agreement.
NEITHER THIS WARRANT NOR THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR ANY OTHER APPLICABLE SECURITIES LAWS IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION...Stock Purchase Warrant • March 28th, 2000 • Nam Corp • Services-legal services
EXCHANGEABLE PREFERRED STOCK AND WARRANTS PURCHASE AGREEMENTExchangeable Preferred Stock and Warrants Purchase Agreement • March 28th, 2000 • Nam Corp • Services-legal services • New York
